Previous
Pause
Siguiente
Skip to Navigation
↓
publicaciones
Año
Año
Año
-Año
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Investigador
Todos
Afif
dyllanes
usuario_prueba
Almeida e Silva, Filomena Augusta
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
Espina Cadena, Laura
Fernandez Antoran, David
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Gómez Candón, David
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Lopes de Sousa Martins, Pedro Alexandre
Martín Yebra, Alba
Martínez Delgado, David
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Título
Título
Año
Identification of FasL as a crucial host factor driving COVID-19 pathology and lethality
2024
Mammalian cell-based production of glycans, glycopeptides and glycomodules
2024
Broad protection against invasive fungal disease from a nanobody targeting the active site of fungal b-1,3-glucanosyltransferases
2024
Detection of Tumor-Associated Autoantibodies in the Sera of Pancreatic Cancer Patients Using Engineered MUC1 Glycopeptide Nanoparticle Probe
2024
A family of di-glutamate mucin-degrading enzymes that bridges glycan hydrolases and peptidases
2024
Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms
2024
Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2
2024
Development of a FUT8 Inhibitor with Cellular Inhibitory Properties
2024
A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain
2023
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses
2023
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
2023
Seroprevalence of anti-SARS-CoV-2 antibodies in household domestic ferrets (Mustela putorius furo) in Spain, 2019-2023.
2023
Systematic Strategy for Developing Glycosyltransferase Inhibitors: Diversity-Oriented Synthesis of FUT8 Inhibitors
2023
Identification of global inhibitors of cellular glycosylation
2023
GalNAc-T isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.
2023
Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation
2023
Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase
2023
The dynamics of neutralizing antibodies against SARS-CoV-2 in cats naturally exposed to virus reveals an increase in antibody activity after re-infection
2023
RTS, S/AS02A malaria vaccine-induced IgG responses equally recognize native-like fucosylated and non-fucosylated Plasmodium falciparum circumsporozoite proteins
2023
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth
2023
Páginas
1
2
3
4
5
6
7
siguiente ›
última »